Premium
Comparative Trial of Sclerotherapy for Hydroceles
Author(s) -
RENCKEN R. K.,
BORNMAN M. S.,
REIF S.,
OLIVIER I.
Publication year - 1990
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1990.tb14761.x
Subject(s) - sclerotherapy , medicine , cure rate , surgery
Summary— We present a prospective single‐blind trial of sclerotherapy for hydroceles with tetradecyl sulphate and rolitetracycline as sclerosants. Twenty‐seven hydroceles were treated with tetradecyl sulphate and 28 with rolitetracycline. The median follow‐up was 13 months. There were no statistically significant differences between the 2 drugs in respect of cure rate and complications. The overall cure rate for both drugs was 96%. Complications were rare and common to both drugs. Tetradecyl sulphate and rolitetracycline were found to be equally effective as sclerosants.